During the past decade, Centre Leon Berard; Oncologie Genetique conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Centre Leon Berard; Oncologie Genetique" are "Breast Cancer" (2 trials) and "Triple Negative Breast Neoplasms" (1 trials). Many other conditions were trialed in "Centre Leon Berard; Oncologie Genetique" in a lesser frequency.

Most popular intervention types in "Centre Leon Berard; Oncologie Genetique" are "Drug" (3 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Capecitabine" (2 trials), "Trastuzumab" (2 trials), "Atezolizumab" (1 trials), "Bevacizumab" (1 trials) and "Carboplatin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centre Leon Berard; Oncologie Genetique" are 2 trials for "Female" genders and 1 trials for "All" genders.

Currently, there are NaN active trials in "Centre Leon Berard; Oncologie Genetique". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Centre Leon Berard; Oncologie Genetique, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Centre Leon Berard; Oncologie Genetique, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".